Research Topic: pediatric mycology

A prospective, multicenter study of invasive fungal disease caused by molds in children and adults in Chile

mycolabadmin

Researchers studied serious fungal infections caused by molds in Chilean hospitals and found that aspergillus was the most common culprit, affecting both children and adults. Many patients with these infections were also suffering from COVID-19, showing how serious respiratory viruses can increase the risk of fungal complications. Good news: the study found no resistance to common antifungal medications in Chile yet, though overall survival rates remain concerning at around 60% at three months.

Read More »

Aspergillus in Children and Young People with Cystic Fibrosis: A Narrative Review

mycolabadmin

Cystic fibrosis is a serious genetic disease affecting children that damages the lungs through chronic infections. Aspergillus, a common mold in the environment, colonizes the airways of CF patients and can cause additional lung damage. While new CFTR modulator medications have improved outcomes and reduced Aspergillus infections, more research is needed to better diagnose and treat fungal infections in children with CF.

Read More »

A Rare Battle: Multidisciplinary Care for a Child with Rhino-Orbital Cerebral Mucormycosis in Somali Region of Ethiopia

mycolabadmin

A 12-year-old girl with poorly controlled diabetes developed a serious fungal infection in her sinuses and eye that spread to her brain. Despite the infection being extremely dangerous, doctors successfully treated her using multiple approaches including antifungal medication, surgery to remove infected tissue, and careful management of her blood sugar. She recovered and went home, though she lost vision in one eye.

Read More »

Disseminated mucormycosis leading to a fatal gastrointestinal perforation in a pediatric case of EBV-associated Hemophagocytic lymphohistiocytosis

mycolabadmin

A 12-month-old girl developed a serious immune system disorder called hemophagocytic lymphohistiocytosis triggered by Epstein-Barr virus infection. Despite aggressive treatment, she developed a life-threatening fungal infection caused by mucormycosis that spread throughout her digestive system. The case illustrates how fungal infections can rapidly progress and become fatal in children with severely weakened immune systems, emphasizing the need for doctors to recognize early warning signs like tissue darkening on the skin.

Read More »

Superficial Fungal Infections in the Pediatric Dermatological Population of Northern Poland

mycolabadmin

This study examined fungal skin infections in children and teens in Northern Poland over six years, finding that about 1 in 5 children tested had a fungal infection. Different types of fungal infections were more common at different ages—younger children more often had scalp infections, while teenagers more often had foot and nail infections. The study found that children living in rural areas had higher infection rates than those in cities, suggesting that environmental factors play an important role in fungal infection patterns.

Read More »

Case Commentary: Successful use of olorofim for the treatment of multi-drug-resistant Lomentospora prolificans infection in a child

mycolabadmin

A young girl contracted a dangerous drug-resistant fungal infection in her knee after an injury, which failed to respond to standard antifungal treatments. Doctors obtained special access to an experimental antifungal drug called olorofim through a compassionate use program. The child showed improvement within two weeks and was completely cured after six months of treatment with no signs of the infection returning two years later, making this the first successful case of this new drug being used in a child.

Read More »

Caspofungin therapy in prosthetic valve endocarditis and candidemia due to itraconazole-resistant Candida glabrata (Nakaseomyces glabratus): A case report

mycolabadmin

A 13-year-old boy developed a serious fungal infection of his heart valve after surgery. The infection was caused by a resistant yeast that didn’t respond to initial antifungal treatment. Doctors used molecular testing to identify the exact fungal species and tested how it responded to different medications. After switching to a different antifungal drug called caspofungin, the patient recovered completely and remained healthy.

Read More »
Scroll to Top